Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 8/26/2025

Discontinuing Methimazole

Key Considerations for Discontinuation

  • The American Academy of Family Physicians recommends standard treatment duration for Graves' disease is typically 12-18 months before considering discontinuation 1, 2
  • Close thyroid function monitoring is essential after methimazole discontinuation, with regular checks of TSH and FT4, especially during the first year after stopping the medication 1, 2, 3
  • The American Academy of Family Physicians suggests that definitive treatment options, such as radioactive iodine (I-131) therapy or thyroidectomy, should be considered if discontinuation is not appropriate 1, 4

Special Considerations

  • Methimazole is contraindicated in the first trimester of pregnancy due to potential teratogenic effects, and propylthiouracil is preferred during this period 5
  • Untreated maternal hyperthyroidism increases risks of preeclampsia, low birth weight, and other complications 1, 2

Monitoring and Management

  • The American Academy of Family Physicians recommends monitoring thyroid function every 1-3 months for the first year after discontinuation, and being vigilant for signs of recurrent hyperthyroidism 1, 2, 3